+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Human Papillomavirus Testing Market Research Report by Product, End-user, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4904933
  • Report
  • October 2021
  • Region: Global
  • 187 pages
  • 360iResearch™
UP TO OFF
until Jan 01st 2022
Global Human Papillomavirus Testing Market is Projected to Reach USD 1,630.81 Million by 2026, Registering a CAGR of 13.38%

FEATURED COMPANIES

  • Abbott Laboratories
  • Arbor Vita
  • Breakspear Medical
  • Cepheid
  • Delphi Bioscience
  • Fujirebio Diagnostics
  • MORE
The Global Human Papillomavirus Testing Market size was estimated at USD 767.33 million in 2020, is expected to reach USD 867.47 million in 2021, and projected to grow at a CAGR of 13.38% reaching USD 1,630.81 million by 2026.



Market Statistics


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage


This research report categorizes the Human Papillomavirus Testing to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Product, the market was studied across Consumables and Systems.
  • Based on End-user, the market was studied across Clinical Diagnostic Laboratories, Hospitals, and Physicians' Office Laboratories.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The analyst's ongoing research amplifies their research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Human Papillomavirus Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Human Papillomavirus Testing Market, including Abbott Laboratories, Arbor Vita, Breakspear Medical, Cepheid, Delphi Bioscience, Fujirebio Diagnostics, Genera Biosystems, IncellDx, OralDNA Labs, and Roche Diagnostics.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Human Papillomavirus Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Human Papillomavirus Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Human Papillomavirus Testing Market?
4. What is the competitive strategic window for opportunities in the Global Human Papillomavirus Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Human Papillomavirus Testing Market?
6. What is the market share of the leading vendors in the Global Human Papillomavirus Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Human Papillomavirus Testing Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Arbor Vita
  • Breakspear Medical
  • Cepheid
  • Delphi Bioscience
  • Fujirebio Diagnostics
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Increasing number of cervical cancer cases and growing aging population
5.2.2. Increasing awareness of cervical cancer screening programs
5.2.3. Government initiatives and funding
5.3. Restraints
5.3.1. Non-availability of HPV test for men
5.4. Opportunities
5.4.1. Introduction of HPV primary screening tests
5.4.2. Increasing Demand for HPV Co-testing
5.5. Challenges
5.5.1. Uncertain reimbursement scenario

6. Human Papillomavirus Testing Market, by Product
6.1. Introduction
6.2. Consumables
6.3. Systems

7. Human Papillomavirus Testing Market, by End-user
7.1. Introduction
7.2. Clinical Diagnostic Laboratories
7.3. Hospitals
7.4. Physicians' Office Laboratories

8. Americas Human Papillomavirus Testing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Human Papillomavirus Testing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand

10. Europe, Middle East & Africa Human Papillomavirus Testing Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, by Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Abbott Laboratories
12.2. Arbor Vita
12.3. Breakspear Medical
12.4. Cepheid
12.5. Delphi Bioscience
12.6. Fujirebio Diagnostics
12.7. Genera Biosystems
12.8. IncellDx
12.9. OralDNA Labs
12.10. Roche Diagnostics

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
Figure 1. Global Human Papillomavirus Testing Market Size, 2020 vs 2026 (USD Million)
Figure 2. Global Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 3. Global Human Papillomavirus Testing Market: Market Dynamics
Figure 4. Global Human Papillomavirus Testing Market Size, by Product, 2020 vs 2026 (%)
Figure 5. Global Human Papillomavirus Testing Market Size, by Product, 2020 vs 2026 (USD Million)
Figure 6. Competitive Strategic Window for Global Human Papillomavirus Testing Market Size, by Product, 2026
Figure 7. Global Human Papillomavirus Testing Market Size, by Consumables, 2018-2026 (USD Million)
Figure 8. Global Human Papillomavirus Testing Market Size, by Consumables, by Region, 2020 vs 2026 (USD Million)
Figure 9. Global Human Papillomavirus Testing Market Size, by Systems, 2018-2026 (USD Million)
Figure 10. Global Human Papillomavirus Testing Market Size, by Systems, by Region, 2020 vs 2026 (USD Million)
Figure 11. Global Human Papillomavirus Testing Market Size, by End-user, 2020 vs 2026 (%)
Figure 12. Global Human Papillomavirus Testing Market Size, by End-user, 2020 vs 2026 (USD Million)
Figure 13. Competitive Strategic Window for Global Human Papillomavirus Testing Market Size, by End-user, 2026
Figure 14. Global Human Papillomavirus Testing Market Size, by Clinical Diagnostic Laboratories, 2018-2026 (USD Million)
Figure 15. Global Human Papillomavirus Testing Market Size, by Clinical Diagnostic Laboratories, by Region, 2020 vs 2026 (USD Million)
Figure 16. Global Human Papillomavirus Testing Market Size, by Hospitals, 2018-2026 (USD Million)
Figure 17. Global Human Papillomavirus Testing Market Size, by Hospitals, by Region, 2020 vs 2026 (USD Million)
Figure 18. Global Human Papillomavirus Testing Market Size, by Physicians' Office Laboratories, 2018-2026 (USD Million)
Figure 19. Global Human Papillomavirus Testing Market Size, by Physicians' Office Laboratories, by Region, 2020 vs 2026 (USD Million)
Figure 20. Americas Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 21. Argentina Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 22. Brazil Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 23. Canada Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 24. Mexico Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 25. United States Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 26. Asia-Pacific Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 27. Australia Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 28. China Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 29. India Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 30. Indonesia Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 31. Japan Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 32. Malaysia Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 33. Philippines Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 34. Singapore Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 35. South Korea Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 36. Taiwan Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 37. Thailand Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 38. Europe, Middle East & Africa Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 39. France Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 40. Germany Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 41. Italy Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 42. Netherlands Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 43. Qatar Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 44. Russia Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 45. Saudi Arabia Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 46. South Africa Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 47. Spain Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 48. United Arab Emirates Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 49. United Kingdom Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Figure 50. Global Human Papillomavirus Testing Market: FPNV Positioning Matrix
Figure 51. Global Human Papillomavirus Testing Market: Share, by Key Player, 2020
Figure 52. Competitive Scenario Analysis in Global Human Papillomavirus Testing Market, by Type

List of Tables
Table 1. Global Human Papillomavirus Testing Market: Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2016–2020
Table 3. Global Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 4. Global Human Papillomavirus Testing Market Size, by Product, 2018-2026 (USD Million)
Table 5. Global Human Papillomavirus Testing Market Size, by Consumables, by Region, 2018-2026 (USD Million)
Table 6. Global Human Papillomavirus Testing Market Size, by Systems, by Region, 2018-2026 (USD Million)
Table 7. Global Human Papillomavirus Testing Market Size, by End-user, 2018-2026 (USD Million)
Table 8. Global Human Papillomavirus Testing Market Size, by Clinical Diagnostic Laboratories, by Region, 2018-2026 (USD Million)
Table 9. Global Human Papillomavirus Testing Market Size, by Hospitals, by Region, 2018-2026 (USD Million)
Table 10. Global Human Papillomavirus Testing Market Size, by Physicians' Office Laboratories, by Region, 2018-2026 (USD Million)
Table 11. Americas Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 12. Argentina Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 13. Brazil Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 14. Canada Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 15. Mexico Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 16. United States Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 17. Asia-Pacific Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 18. Australia Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 19. China Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 20. India Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 21. Indonesia Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 22. Japan Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 23. Malaysia Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 24. Philippines Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 25. Singapore Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 26. South Korea Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 27. Taiwan Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 28. Thailand Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 29. Europe, Middle East & Africa Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 30. France Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 31. Germany Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 32. Italy Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 33. Netherlands Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 34. Qatar Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 35. Russia Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 36. Saudi Arabia Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 37. South Africa Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 38. Spain Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 39. United Arab Emirates Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 40. United Kingdom Human Papillomavirus Testing Market Size, 2018-2026 (USD Million)
Table 41. Global Human Papillomavirus Testing Market: Scores
Table 42. Global Human Papillomavirus Testing Market: Business Strategy
Table 43. Global Human Papillomavirus Testing Market: Product Satisfaction
Table 44. Global Human Papillomavirus Testing Market: Ranking
Table 45. Global Human Papillomavirus Testing Market: Share, by Key Player, 2020
Table 46. Global Human Papillomavirus Testing Market: Merger & Acquisition
Table 47. Global Human Papillomavirus Testing Market: Agreement, Collaboration & Partnership
Table 48. Global Human Papillomavirus Testing Market: New Product Launch & Enhancement
Table 49. Global Human Papillomavirus Testing Market: Investment & Funding
Table 50. Global Human Papillomavirus Testing Market: Award, Recognition & Expansion
Table 51. Global Human Papillomavirus Testing Market: License & Pricing
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Arbor Vita
  • Breakspear Medical
  • Cepheid
  • Delphi Bioscience
  • Fujirebio Diagnostics
  • Genera Biosystems
  • IncellDx
  • OralDNA Labs
  • Roche Diagnostics
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll